Loading...

High-dose atorvastatin reduces the risk of cardiovascular events in patients with percutaneous coronary intervention

We systematically searched in PubMed, Web of Science, Embase and China National Knowledge Infrastructure from the inception to March 31, 2017, identified relevant trials about efficacy of high-does Atorvastatin for patients with percutaneous coronary intervention. Twelve studies with the number of 2...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget
Main Authors: Lu, Changqing, Jia, Helei, Wang, Zhentao
Format: Artigo
Language:Inglês
Published: Impact Journals LLC 2017
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5642560/
https://ncbi.nlm.nih.gov/pubmed/29050285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19701
Tags: Add Tag
No Tags, Be the first to tag this record!